---
figid: PMC7256023__18_2019_3398_Fig1_HTML
figtitle: TGFBeta-induced epithelial-to-mesenchymal transition
organisms:
- Candida dubliniensis
- Solanum tuberosum
- Homo sapiens
- Mus musculus
- Human gammaherpesvirus 4
- Ithyoclinostomum yamagutii
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7256023
filename: 18_2019_3398_Fig1_HTML.jpg
figlink: pmc/articles/PMC7256023/figure/Fig1/
number: F1
caption: TGFβ-induced epithelial-to-mesenchymal transition. TGFβ signaling can be
  activated by TGFβ ligands and activate both canonical (blue) and non-canonical pathways
  (grey). In the canonical SMAD pathway, TGFβR2 activated TGFβR1 phosphorylates SMAD2
  and SMAD3, which subsequently form a complex with SMAD4 and translocate to the nucleus.
  Upon DNA binding, the SMAD complex activates drivers of EMT (SNAI1/2, ZEB1/2 and
  TWIST1/2) as well as negative feedback component SMAD7. SMAD7 negative feedback
  regulates TGFβ signaling via recruiting the E3 ubiquitin ligase SMURF2 to activated
  TβR1/2 receptors and then targets the receptors for degradation. SMAD-independent
  activation of PI3K/AKT, RHO and RAS/MAPK pathways by TGFβ are non-canonical effectors
  also involved in EMT and survival. Cancer cells undergoing EMT lose epithelial properties,
  including cell–cell adhesion, apical–basal polarity and the decrease expression
  of epithelial genes, i.e. E-cadherin, ZO-1, laminin-1, occludin, claudin. Subsequently,
  cancer cells acquire migratory mesenchymal characteristics, involving tight-junction
  dissociation and increased expression of mesenchymal markers, i.e. N-cadherin, vimentin
  and fibronectin
papertitle: TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal
  transition in cancer.
reftext: Wan Hua, et al. Cell Mol Life Sci. 2020;77(11):2103-2123.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.954843
figid_alias: PMC7256023__F1
figtype: Figure
redirect_from: /figures/PMC7256023__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7256023__18_2019_3398_Fig1_HTML.html
  '@type': Dataset
  description: TGFβ-induced epithelial-to-mesenchymal transition. TGFβ signaling can
    be activated by TGFβ ligands and activate both canonical (blue) and non-canonical
    pathways (grey). In the canonical SMAD pathway, TGFβR2 activated TGFβR1 phosphorylates
    SMAD2 and SMAD3, which subsequently form a complex with SMAD4 and translocate
    to the nucleus. Upon DNA binding, the SMAD complex activates drivers of EMT (SNAI1/2,
    ZEB1/2 and TWIST1/2) as well as negative feedback component SMAD7. SMAD7 negative
    feedback regulates TGFβ signaling via recruiting the E3 ubiquitin ligase SMURF2
    to activated TβR1/2 receptors and then targets the receptors for degradation.
    SMAD-independent activation of PI3K/AKT, RHO and RAS/MAPK pathways by TGFβ are
    non-canonical effectors also involved in EMT and survival. Cancer cells undergoing
    EMT lose epithelial properties, including cell–cell adhesion, apical–basal polarity
    and the decrease expression of epithelial genes, i.e. E-cadherin, ZO-1, laminin-1,
    occludin, claudin. Subsequently, cancer cells acquire migratory mesenchymal characteristics,
    involving tight-junction dissociation and increased expression of mesenchymal
    markers, i.e. N-cadherin, vimentin and fibronectin
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Ltbp1
  - Prep
  - Smurf2
  - Pik3r1
  - Smad7
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Smad2
  - Smad3
  - Rho
  - Rhod
  - Ea2
  - Ephb2
  - Mapk1
  - Smad4
  - Zeb2
  - Zeb1
  - Twist1
  - Twist2
  - Snai1
  - Cdh1
  - Fzr1
  - Tjp1
  - Cdh2
  - Itk
  - Slc22a3
  - Tgfbr1
  - TGFB1
  - TGFB2
  - TGFB3
  - SMURF2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SMAD7
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - SMAD2
  - SMAD3
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - EPHB2
  - MAPK1
  - MAPK3
  - SMAD4
  - ZEB2
  - ZEB1
  - TWIST1
  - TWIST2
  - SNAI1
  - CDH1
  - FZR1
  - TJP1
  - CDH2
  - ITK
  - SLC22A3
  - TGFBR1
  - smurf2
  - smad7
  - rab1ab
  - smad2
  - smad3a
  - rho
  - rnd2
  - smad4a
  - smad4b
  - zeb1b
  - twist1a
  - twist2
  - twist3
  - snai1a
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - cldn10e
  - cdh2
  - tgfbr1a
---
